中興商業(000715.SZ):瀋陽國際科技擬減持不超2%股份
格隆匯8月6日丨中興商業(000715.SZ)公佈,持有公司股份831.43萬股(佔公司總股本比例2.00%)的股東瀋陽國際科技開發公司(以下簡稱“瀋陽國際科技”)計劃在本公告披露之日起15個交易日後的六個月內以集中競價交易方式或大宗交易方式減持公司股份不超過831.43萬股(佔公司總股本比例2.00%)。瀋陽國際科技及其一致行動人瀋陽中興商業集團有限公司合計持有公司股份2849.84萬股(佔公司總股本比例6.86%)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.